On Jan. 07, Napierski Ryan S divested U.S. $286,038 in shares of Nu Skin Enterprises Inc.. The Pres sold 4,844 shares at a price per share of $59.05. The transaction decreased this specific insider’s holdings to 75,256 shares worth around $4.23 million at present.
BofA Securities took its Nu Skin Enterprises Inc. [NUS] rating to the equivalent of a Neutral from an Underperform, and the price target to $58 from $54, in a research note dated October 02, 2020. That figure represents around a 3.12% premium from where the company’s shares closed on Friday. Other analysts also revised their coverage, with BofA Securities’s analysts upgrading the shares from “an Underperform” rating to “a Neutral” rating in a research note to investors issued in early October. Meanwhile, Jefferies had raised its rating on NUS to “Buy” from the earlier “Hold”, in a research note produced for clients July 02, 2020. In addition, there was an upgrade from DA Davidson on July 02, 2020. The rater changed NUS from “a Neutral” to “a Buy”.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Get the hottest stocks to trade every day before the market opens 100% free. Click here now.
Is Nu Skin Enterprises Inc. [NYSE:NUS] a Good Buy Right Now?
It should be noted that NUS technical indicators for short, intermediate as well as long term progress have placed an overall average of 100% as Buy. The average signal changed from 100% Buy in the last week and compares with 56% Buy in the past month. Data from Nu Skin Enterprises Inc.’s Trend Spotter indicated that the signals were Weakest. The stock current average is 0.35 million shares in the past 20 days and the short term average signal indicates a 100% Buy. In the last 50 days, the average trading volume was 0.38 million shares while the medium term average advocated for 100% Buy. The average long-term signal stands at 100% Buy and the 100-day average volume stands at 0.39 million shares.
NUS Price Performance
On Wall Street, Nu Skin Enterprises Inc. [NYSE:NUS] finished Friday’s session down -2.77% at $56.19. The stock went up to $58.22 at the same session while its lowest single day price was $55.14. In the last five days, it saw a rise of about 2.86%, Nu Skin Enterprises Inc. shares gained by almost 2.86% since the beginning of the year. However, the share price has dropped to as low as -5.13% below its one year high. On 01/07/21, the company shares recorded $59.23, the highest single-day price it has got to in the last 52-weeks and a 52-week low was seen on 01/04/21, the same year at $54.25. The company’s shares have inclined by 37.65% in the past year. The 50-day SMA achieved is $52.49 while the 200-day SMA is $43.99. Volume gained to 0.55 million from 0.4 million in the previous session.
Nu Skin Enterprises Inc. [NUS] Valuation Measures
Notably, Nu Skin Enterprises Inc. [NUS] stock can be classified as a good candidate in the listing of underestimated low-priced Household & Personal Products companies to purchase soonest possible with the prevailing 12-month PE ratio of 18.98. The measure means the stock is exchanging at a discount as compared to the 19.90x trailing earnings of the industry. It can be helpful for investors to consider historical price-sales ratio, more specifically, a 1.22 PS value ratio is reported for the last one year of reported earnings. That is higher than the industry average of 1.06 which means NUS serve an attractive investment opportunity compared to its competitors.
NUS Stock Support And Resistance Levels
On the 24-hour scale, the immediate backing is perceived around 54.81 level, and in case of violation of this particular level, it will cause more drop to 53.44 level. On the upper level, 59.60 is still the key resistance. The stock may increase to the subsequent resistance at 57.89. The Relative Strength Index (RSI) pinned on the 14-day chart is 59.33, implying a neutral technical stance while the MACD stands at 2.78, meaning price will increase in the next trading period. Percent R indicator moved to 34.27%, implying low price movement. Stochastic %K at 82.23% suggest selling the stock.
What is the short interest in Nu Skin Enterprises Inc.?
Short interest in the Nu Skin Enterprises Inc. stock has plunged, decreasing by -0.34 million shares to total 1.19 million shares on Dec 14, 2020. The interest had seen shares on Nov 12, 2020 stand at 0.85 million, data from Yahoo Finance shows. The increase of 28.84% suggests the stock saw some increased bearish sentiment. The stock’s days to cover (short ratio) moved to while the shorted shares account for just 3.16% of the overall float for the stock.
Nu Skin Enterprises Inc.’s Biggest Shareholders: Who Owns Nu Skin Enterprises Inc. [NUS]?
Filings by BlackRock Fund Advisors showed that the firm now holds a total of 4,843,014 shares or roughly 9.49% of the outstanding NUS shares. This means their shares have reduced by -376,470 from the 4,843,014 the investor reportedly held in its prior 13-F filing. With the conclusion of the sale, The Vanguard Group, Inc. updated stake is worth $241,239,719. Details in the latest 13F filings reveal that Wellington Management Co. LLP disposed off their -1.94% stake valued at $159,247,543 while Renaissance Technologies LLC added theirs at $121,383,315. During the last quarter, Wellington Management Co. LLP liquidated -61,075 of its shares in Nu Skin Enterprises Inc. while Renaissance Technologies LLC bought 580,100 shares. The Dimensional Fund Advisors LP’s holdings currently number 2,022,872 shares at $113665177.68. According to the firm’s last 13F report, SSgA Funds Management, Inc. shares in the company at filing stood at 1,427,170 shares, roughly $73,513,527.
NUS Earnings Forecast For The Current Quarter
Nu Skin Enterprises Inc. [NUS] is expected to report strong earnings results for the quarter ending on Dec 2020. Consensus estimates give the company expected revenues of $745.53M and an earnings per share of $1.18 for Dec 2020. Looking further ahead, the company is expected to report revenue of $649.62M at an EPS of $0.74 for Mar 2021. The estimates represent upside of 10.70% and 11.16% in the company’s revenue and earnings per share, respectively, on a year-on-year basis.
NUS Earnings Estimates For The Current Year
For the financial year, Nu Skin Enterprises Inc. [NYSE:NUS] is expected to bring in revenue of $2.58B. The returns are nearly $160.0 million higher than the company’s actual revenue recorded in the fiscal year 2019. In terms of EPS for the 2020, estimate put it at 3.4, higher than that of FY19 by $0.3. Estimates put this year’s earnings growth at 9.70%, 11.20% for the next, and at an annual 9.05% over the next 5-year period. As for sales, forecasts are for an increase of 6.60% in the current fiscal year and a further 10.70% over the following year.
Get the hottest stocks to trade every day before the market opens 100% free. Click here now.
What are analyst thoughts on Nu Skin Enterprises Inc.?
Looking forward to the Nu Skin Enterprises Inc. share price prediction, we can see that analysts, surveyed by FactSet, offer the mean price target for Nu Skin Enterprises Inc. stock at $60.00 within the next 12 months, which represents almost 6.35 per cent growth from its previous closing price of $56.19. The highest analysts’ target for Nu Skin Enterprises Inc. stock projections is $80.00 and the lowest one is $55.00. Still, 7 analysts sharing their consensus rating for NUS stock in 2021 agree that it is an Overweight.
